ArticleJournal of the American Chemical Society2022

A Polymer Prodrug Strategy to Switch from Intravenous to Subcutaneous Cancer Therapy for Irritant/Vesicant Drugs.

Alexandre Bordat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.